Top

How to fortify the immunity of HIV patients

March 6, 2010 by admin · Leave a Comment 

Contact: Sophie Langlois
sophie.langlois@umontreal.ca
514-773-0104
University of Montreal Read more

HIV vaccine strategy expands immune responses

March 2, 2010 by admin · Leave a Comment 

Contact: James E. Rickman
jamesr@lanl.gov
505-665-9203
DOE/Los Alamos National Laboratory Read more

Pneumococcal vaccine offers protection to HIV-infected African adults in clinical trial

March 2, 2010 by admin · Leave a Comment 

Contact: Craig Brierley
c.brierley@wellcome.ac.uk
44-207-611-7329
Wellcome Trust
A clinical trial of a vaccine against a major cause of pneumonia and meningitis has shown that it can prevent three out of four cases of re-infection in HIV-infected adults in Africa.

Read more

Gene-based stem cell therapy specifically removes cell receptor that attracts HIV

February 24, 2010 by admin · Leave a Comment 

Contact: Enrique Rivero
erivero@mednet.ucla.edu
310-794-2273
University of California - Los Angeles
UCLA AIDS Institute researchers successfully removed CCR5 a cell receptor to which HIV-1 binds for infection but which the human body does not need from human cells. Individuals who naturally lack the CCR5 receptor have been found to be essentially resistant to HIV.

Read more

Combined drug therapy to treat TB and HIV significantly improves survival

February 24, 2010 by admin · Leave a Comment 

Contact: Stephanie Berger
sb2247@columbia.edu
212-305-4372
Columbia University’s Mailman School of Public Health
Initiating antiretroviral therapy (ART) during tuberculosis therapy significantly reduced mortality rates by 56 percent in a randomized clinical trial of 642 patients co-infected with HIV and tuberculosis. The study, which provides further impetus for the integration of TB and HIV services, lays to rest the controversy on whether co-infected patients should initiate ART during or after TB treatment. Findings are published in the February 25th issue of The New England Journal of Medicine.

Read more

Penn researchers present Phase II HIV gene therapy trial data at CROI 2010

February 17, 2010 by admin · Leave a Comment 

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine Read more

Scientists discover origin of HIV transmission among male partners

February 9, 2010 by admin · Leave a Comment 

Contact: Debra Kain
ddkain@ucsd.edu
619-543-6163
University of California - San Diego
A team of scientists, led by a virologist from the University of California, San Diego’s Center for AID Research (CFAR), has discovered the origin of strains of human immunodeficiency virus (HIV) among men who have sex with men. The study, which may be important in developing prevention strategies for HIV, will appear in Science Translational Medicine on February 10, 2010.

Read more

Researchers reveal 3-D structure of bullet-shaped virus with potential to fight cancer, HIV

February 7, 2010 by admin · Leave a Comment 

Contact: Jennifer Marcus
jmarcus@cnsi.ucla.edu
310-267-4839
University of California - Los Angeles Read more

Scientists find two compounds that lay the foundation for a new class of AIDS drug

February 2, 2010 by admin · Leave a Comment 

Contact: Keith McKeown
kmckeown@scripps.edu
858-784-8134
Scripps Research Institute Read more

HIV researchers solve key puzzle after 20 years of trying

January 30, 2010 by admin · Leave a Comment 

Contact: Laura Gallagher
l.gallagher@imperial.ac.uk
44-020-759-48432
Imperial College London
Researchers have made a breakthrough in HIV research that had eluded scientists for over 20 years, potentially leading to better treatments for HIV, in a study published today in the journal Nature.

Read more

Next Page »

Bottom